Western Wealth Management, LLC Alpine Immune Sciences, Inc. Transaction History

Western Wealth Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	BUY	$17.75 - $41.6 $1,242 - $2,912	70 Added 0.58%	12,070 $478,000
Q4 2022 Feb 02, 2023	SELL	$5.45 - $7.35 $65,400 - $88,200	-12,000 Reduced 50.0%	12,000 $88,000
Q3 2022 Nov 04, 2022	SELL	$6.89 - $9.39 $7,716 - $10,516	-1,120 Reduced 4.46%	24,000 $172,000
Q2 2022 Jul 18, 2022	BUY	$6.71 - $9.52 $168,555 - $239,142	25,120 New	25,120 $214,000
Q1 2022 May 10, 2022	SELL	$6.41 - $13.89 $79,227 - $171,680	-12,360 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$10.41 - $13.95 $3,747 - $5,022	360 Added 3.0%	12,360 $171,000
Q2 2021 Aug 09, 2021	BUY	$8.81 - $15.03 $105,720 - $180,360	12,000 New	12,000 $108,000

56.2K

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

Get notified when there are updates to the investment portfolio of Western Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Western Wealth Management, LLC with notifications on news.